CIK: 1280154 - Address: C/o Urovant Sciences, Inc., 5281 California Avenue, Suite 100, Irvine, CA 92617
15 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret116-0-40171625
S%wins831005017257558

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/18/14 20:55
12/16/14
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOcampo ChristineCAOVP,FinanS.dm-60616.940-36-25109D
10/24/14 20:22
10/24/14
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOcampo ChristineCAOVP,FinanS-2511.810-2-378D
9/17/14 20:44
9/15/14
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOcampo ChristineCAOVP,FinanS.d-5209.450-55-4180D
8/28/14 21:03
8/26/14
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOcampo ChristineCAOVP,FinanS-136.100-2-380D
5/16/14 20:00
5/14/14
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOcampo ChristineCAOVP,FinanS.m-1895.050-37-3185M
12/20/13 17:26
12/18/13
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOcampo ChristineCAOVP,FinanS-62.630-2-378D
5/17/13 20:01
5/15/13
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOcampo ChristineCAOVP,FinanS.d-2553.290-78-4981D
12/5/12 16:40
12/3/12
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOcampo ChristineCAOVP,FinanS-72.550-3-470D
9/19/12 16:31
9/17/12
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOcampo ChristineCAOVP,FinanS.d-2273.490-65-4773D
12/6/11 17:00
12/2/11
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOcampo ChristineCAOVP,FinanS-62.384-3-550D37-33-34-6-13-1244-1-11-1810
11/14/11 17:11
11/11/11
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOcampo ChristineCAOVP,FinanS.d-2422.622-92-6453D44-44-32-100-9-5-33-3-2314
12/8/10 12:38
12/6/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOcampo ChristineCAOVP,FinanS-523.7916-14-2151D999106564334-16-9-5-1-3103-2-34
12/3/10 20:59
12/2/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOcampo ChristineCAOVP,FinanS.dm-1944.0919-47-4265D999122664041-16-7-5-3-34-1112-40
8/13/10 18:27
8/11/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOcampo ChristineCAOVP,FinanS.d-883.114-28-3454D2152366137-7-7-60-4-135628-4
3/17/10 18:00
3/16/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsOcampo ChristineCAOVP,FinanS-322.081-16-2254D111369-21617156-30-141322784

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact